Drug Type Live biotherapeutic products |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Vaginosis | Phase 2 | - | 08 Jul 2024 | |
| Candidiasis, Vulvovaginal | Phase 2 | - | 08 Jul 2024 | |
| Infective vaginitis | Phase 2 | - | 08 Jul 2024 | |
| Vaginitis | Phase 2 | - | - |





